Why Shares of Surmodics Jumped This Week
The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.
Why Shares of Surmodics Soared on Tuesday
An analyst upgrade gave the stock a boost.
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March...
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounceâ„¢ Thrombectomy System
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first patient in PROWL, the Pounceâ„¢ Thrombectomy System Retrospective...